Jun 30, 2026 07:58AM

Jun 9, 2026 08:31AM

Feb 6, 2026 04:14PM

Dec 17, 2025 02:36PM

Dec 17, 2025 02:21PM

Dec 17, 2025 12:20PM

Dec 17, 2025 12:01PM William Blair Downgrades VistaGen Therapeutics (VTGN) to Market Perform

Dec 17, 2025 10:40AM

Dec 17, 2025 09:35AM

Nov 26, 2025 08:30AM

Nov 25, 2025 10:54AM

Nov 17, 2025 09:26AM

Nov 14, 2025 12:23AM

Nov 4, 2025 04:53AM Increasing unusual call option volume: MET XLB KMB QURE VITL BBD ACVA AGL VTGN

Jun 25, 2025 08:36AM

Jun 18, 2025 10:47AM

Jun 2, 2025 08:31AM

Feb 5, 2025 08:32AM

Jan 14, 2025 08:33AM

Nov 20, 2024 04:39PM

Sep 23, 2024 08:31AM VistaGen Therapeutics (VTGN) Initiates PALISADE-4 Phase 3 Study of Fasedienol

418,087 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All